Meet Guido Hita, M.D.
About Dr. Hita
Dr. A. Guido Hita is a provider in the MD Anderson Emergency Center and an Assistant Professor in the Department of Emergency Medicine. He is board-certified in Internal Medicine and joined MD Anderson in 2011.
Assistant Professor, Department of Emergency Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
|2003||Medical College of Wisconsin: School of Public Health, Milwaukee, WI, USA, MPH, Public Health|
|1983||Universidad Nacional Autonoma de Mexico: Facultad de Estudios Superiores Zaragoza, Mexico City, MEX, MD, Medicine|
|1978||Colegio de Ciencias y Humanidades Plantel ORIENTE- Universidad Nacional Autonoma de Mexico, Mexico City, MEX, BS, Biology and Chemistry|
|1990-1993||Clinical Residency, Internal Medicine, o Saint Elizabeth Health Center \ Northeastern Ohio University College of Medicine (NEOUCOM), Youngstown, OH|
|1986-1986||Clinical Residency, Internal Medicine, Dr. Fernando Quiroz Medical Center\ Universidad Nacional Autonoma de Mexico (UNAM), Mexico City|
|1984-1985||Clinical Residency, Obstetrics, Pediatrics, Internal Medicine and Surgery, Ignacio Zaragoza General Hospital\I Universidad Nacional Autonoma de Mexico (UNAM), Mexico City|
|1995||American Board of Internal Medicine|
Assistant Professor, Department of General Internal Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2013
Institutional Committee Activities
Member, Faculty Senate, University of Texas MD Anderson Cancer Center, 2012 - 2013
Rice University, Department of Bioengineering, Houston, Texas, 2012 - Present
- Naidu GN, Acharya GK, Alagappan K, Hita AG. Hyponatremia-Induced Seizures Secondary to Magnesium Citrate Colon Cleansing Agent. Emerg Med (Los Angel)(7):358, 2017.
- Elting LS, Chang YC, Parelkar P, Boers-Doets CB, Michelet M, Hita G, Rouleau T, Cooksley C, Halm J, Vithala M, Bossi P, Escalante C, Brennan MT, On behalf of the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Risk of oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: a meta-analysis. Support Care Cancer. e-Pub 2013. PMID: 23636648.